Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.34 USD | -6.48% | -1.11% | -31.45% |
05/06 | Transcript : Syros Pharmaceuticals, Inc. - Shareholder/Analyst Call | |
14/05 | Transcript : Syros Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 14, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-31.45% | 14Cr | |
+34.01% | 5.11TCr | |
+33.84% | 3.89TCr | |
-8.02% | 3.88TCr | |
-8.98% | 2.67TCr | |
+12.56% | 2.63TCr | |
-19.62% | 1.95TCr | |
+39.18% | 1.36TCr | |
+31.47% | 1.25TCr | |
-3.40% | 1.17TCr |
- Stock Market
- Equities
- SYRS Stock
- News Syros Pharmaceuticals, Inc.
- Earnings Flash (SYRS) SYROS PHARMACEUTICALS Reports Q2 Revenue $2.8M, vs. Street Est of $3.5M